Abstract

Many clinicians suspect that treatment with an oral corticosteroid increases the risk of developing peptic ulcers and can induce bleeding or perforation in patients who already have one. This may affect the decision to use steroid treatment, and may influence the management of peptic ulcer in patients already receiving a steroid. What is the evidence for these views?